Abstract
The present study assessed the acute effects of smoked marijuana on social conversation. Speech quantity was recorded continuously in seven moderate marijuana users during separate 1 h experimental sessions following the paced smoking of 0, 1.01, 1.84, and 2.84% THC marijuana cigarettes. Subjects engaged in conversation with undrugged partners who smoked placebo marijuana cigarettes. The active marijuana produced significant decreases in speech quantity, increases in heart rate, and increases in self-reports of “high” and sedation. Partners showed no effects in speech quantity or self-reports of drug effects that were systematically related to the doses administered to the subject pair members. The effects on speech quantity observed in the present study after acute dosing are similar to the effects on social conversation reported previously during chronic marijuana dosing. Marijuana appears to be an exception to the general rule that drugs of abuse increase verbal interaction.
Similar content being viewed by others
References
Babor TE, Rossi AM, Sagotsky G, Meyer RE (1974a) Group behavior: Patterns of smoking. In: Mendelson JH, Rossi AM, Meyer RE (eds) The use of marijuana: A psychological and physiological inquiry. Plenum Press, New York, pp 47–59
Babor TF, Rossi AM, Sagotsky G, Meyer RE (1974b) Group behavior: Verbal interaction. In: Mendelson JH, Rossi AM, Meyer RE (eds) The use of marijuana: A psychological and physiological inquiry. Plenum Press, New York, pp 61–72
Babor TF, Meyer RE, Mirin SM, McNamee HB, Davies M (1976) Behavioral and social effects of heroin self-amdinistration and withdrawal. Arch Gen Psychiatry 33:363–367
Babor TF, Mendelson JH, Uhly B, Kuehnle JC (1978a) Social effects of marijuana use in a recreational setting. Int J Addict 13:947–959
Babor TF, Mendelson JH, Gallant BA, Kuehnle JC (1978b) Interpersonal behavior in group discussion during marijuana intoxication. Int J Addict 13:89–102
Babor TF, Berglas S, Mendelson JH, Ellingboe J, Miller K (1983) Alcohol, affect, and the disinhibition of verbal behavior. Psychopharmacology 80:53–60
Cocchetto DM, Owens SM, Perez-Reyes M, DiGuiseppi S, Miller LL (1981) Relationship between plasma delta-9-tetrahydrocannabinol concentration and pharmacologic effects in man. Psychopharmacology 75:158–164
Docter RF, Bernal ME (1964) Immediate and prolonged psychophysiological effects of sustained alcohol intake in alcoholics. Q J Stud Alc 25:438–450
Feldstein S, Weingartner H (1981) Speech and psychopharmacology. In: Darby JK (ed) Speech evaluation in psychiatry. Grune Stratton, New York, pp 369–396
Fraser HF, Jones BE, Rosenberg DE, Thomposon AK (1963) Effects of addiction to intravenous heroin on patterns of physical activity in man. Clin Pharmacol Ther 4:188–196
Gottschalk LA, Bates DE, Waskow IE (1971) Effect of amphetamine or chlorpromazine on achievement striving scores derived from content analysis of speech. Comp Psychiatry 12:430–436
Griffiths RR, Bigelow GE, Liebson I (1975) Effects of ethanol self administration on choice behavior: Money vs. socializing. Pharmacol Biochem Behav 3:443–446
Griffiths RR, Stitzer M, Corker K, Bigelow GE, Liebson I (1977) Drug produced changes in human social behavior: Facilitation by d-amphetamine. Pharmacol Biochem Behav 7:365–372
Haines L, Green W (1970) Marijuana use patterns. Br J Addict 65:347–362
Haertzen CA (1966) Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory “ARCI”. Psychol Rep 18:163–194
Janowsky DS, Clopton PL, Leichner PP, Abrams AA, Judd LL, Pechnick R (1979) Interpersonal effects of marijuana: A model for the study of interpersonal psychopharmacology. Arch Gen Psychiatry 36:781–785
Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 12:245–258
Miller LL, Cocchetto DM, Perez-Reyes M (1983) Relationships between several pharmacokinetic parameters and psychometric indices of subjective effects of Δ9-tetrahydrocannabinol in man. Eur J Clin Pharmacol 25:633–637
Paul MI, Carson IM (1973) Marijuana and communication. Lancet 7823:270–271
Perez-Reyes M, Owens SM, Di Guiseppi S (1981) The clinical pharmacology and dynamics of marijuana cigarette smoking. J Clin Pharmacol 21:201S-207S
Perez-Reyes M, Di Guiseppi S, Davis KH, Schindler VH, Cook CE (1982) Comparison of effects of marijuana cigarettes of three different potencies. Clin Pharmacol Ther 31:617–624
Smith RC, Parker ES, Noble EP (1975) Alcohol's effect on some formal aspects of verbal social communication. Arch Gen Psychiatry 32:1394–1398
Stitzer ML, Griffiths RR, Bigelow GE, Liebson I (1981a) Social stimulus factors in drug effects in human subjects. Natl Inst Drug Abuse Res Monogr 37:130–154
Stitzer ML, Griffiths RR, Bigelow GE, Liebson I (1981b) Human social conversation: Effects of ethanol, secobarbital and chlorpromazine. Pharmacol Biochem Behav 14:353–360
Stitzer ML, McCaul ME, Bigelow GE, Liebson IA (1984) Hydromorphone effects on human conversational speech. Psychopharmacology 84:402–404
Tart CT (1970) Marijuana intoxication: Common experiences. Nature 226:701–704
Thornton CC, Alterman AI, Skoloda TE, Gottheil E (1976) Drinking and socializing in “introverted” and “extroverted” alcoholics. Ann NY Acad Sci 273:481–487
Waskow IE (1967) The effects of drugs on speech: A review. In: Salzinger K, Salzinger S (eds) Research in verbal behavior and some neurophysiological implications. Academic Press, New York, pp 356–381
Weil AT, Zinberg NE (1969) Acute effects of marijuana on speech. Nature 222:434–437
Zeidenberg P, Clark C, Jaffe J, Anderson SW, Chin S, Malitz S (1973) Effect of oral administration of Δ9 tetrahydrocannabinol on memory, speech and perception of thermal stimulation: Results with four normal human volunteer subjects, preliminary report. Comp Psychiatry 14:549–556
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Higgins, S.T., Stitzer, M.L. Acute marijuana effects on social conversation. Psychopharmacologia 89, 234–238 (1986). https://doi.org/10.1007/BF00310635
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00310635